About Us

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.

It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.

Led by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.

We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.

At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.

These values are the foundation of our work, empowering us to make a real difference, every day.

Position Title: Senior Manager, SEC Reporting & Technical Accounting

Department: Accounting

Reports To: Director, SEC & Technical Accounting

Location: Princeton, NJ or South San Francisco, CA – On-site 4 days per week (Mon to Thurs)

Job Overview

Kardigan is seeking an experienced and detail-driven Senior Manager, SEC Reporting & Technical Accounting to play a critical role in supporting the Company's financial reporting and accounting functions as we continue to scale as a public company. This position will lead the preparation and coordination of quarterly and annual SEC filings, provide technical accounting leadership on complex transactions, and oversee the Company's SOX compliance program.

The successful candidate will partner closely with Accounting & Finance leadership, external auditors, and cross-functional stakeholders to ensure accurate financial reporting, compliance with U.S. GAAP and SEC requirements, and an effective internal control environment. This role requires deep experience preparing Forms 10-Q and 10-K, researching technical accounting matters, and supporting a public biotechnology or biopharmaceutical company. Experience with SOX compliance, process improvement, and leveraging automation and AI technologies to enhance reporting processes is strongly preferred.

Essential Duties and Responsibilities

Financial Reporting & Compliance

Lead the preparation, review, and coordination of quarterly and annual SEC filings, including Forms 10-Q, 10-K, earnings releases, and related financial disclosures. Partner with Accounting leadership and external auditors to ensure accurate, timely, and compliant external financial reporting in accordance with U.S. GAAP and SEC requirements. Assist with the implementation of new accounting standards and disclosure requirements.

Technical & Operational Accounting

Serve as the subject matter expert on technical and operational accounting matters, including stock-based compensation, lease accounting, equity transactions, licensing arrangements, collaboration agreements, business development transactions, revenue recognition, and other complex accounting areas. Research and evaluate the accounting implications of new transactions, prepare technical accounting memoranda, document accounting conclusions, and ensure compliance with U.S. GAAP and company policies. Partner with cross-functional stakeholders to support complex business initiatives and the implementation of new accounting standards. Support accounting analyses related to strategic collaborations, business development activities, acquisitions, and future commercialization initiatives as the company continues to grow.